Contoura With Phorcides Compared to Wavefront Optimized LASIK

Description

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Conditions

Myopia, Astigmatism

Talk to us

Study Overview

On this page

Study Details

Study overview

Comparing post-operative visual acuity and patient reported satisfaction between Contoura with Phorcides and WaveLight Wavefront Optimized.

Comparison of Visual Acuity and Quality of Life Following Contoura With Phorcides Compared to WaveLight Wavefront Optimized LASIK

Contoura With Phorcides Compared to Wavefront Optimized LASIK

Condition
Myopia
Intervention / Treatment

-

Contacts and Locations

Bozeman

Vance Thompson Vison, Bozeman, Montana, United States, 57105

Omaha

Vance Thompson Vision, Omaha, Nebraska, United States, 57105

Fargo

Vance Thompson Vision, Fargo, North Dakota, United States, 57105

Sioux Falls

Vance Thompson Vision, Sioux Falls, South Dakota, United States, 57108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients at least age 21 years of age undergoing LASIK eye surgery
  • * Willing and able to comprehend informed consent and complete 1 month post-op visit
  • * Potential postoperative BCDVA of 20/20 or better in each eye based on Investigator's medical opinion
  • * Candidates for Contoura with Phorcides (Myopic, astigmatism \<3.0D)
  • * Both eyes targeted for plano
  • * Pre-operative total corneal Pachymetry 490um or above
  • * Stable refractive error \<0.50D change in preceding year
  • * Good general and ocular health
  • * Pre-operative exam completed within three months of surgery
  • * SCL discontinued 3 days prior to pre-op exam and the procedure
  • * Pachymetry above 490 with residual greater than 270um
  • * Candidates who, as determined by the investigator, can safely undergo LASIK
  • * Patients under 21 years of age
  • * Concomitant ocular condition which would limit the BCVA at the discretion of the surgeon
  • * Patients with usual relative and absolute contraindications for LASIK surgery (Patients with severe dry eye, recurrent corneal erosion, uncontrolled Glaucoma, collagen vascular disorders, keratoconus or signs of keratoconus, uncontrolled Diabetes, Herpes)
  • * Pachymetry below 490
  • * Autoimmune or immunodeficiency diseases
  • * Pregnant or nursing women
  • * Patients with signs of inability to understand consent for study and procedure planned
  • * Patients with history of previous ocular surgery
  • * Patients with strabismus or amblyopia
  • * Patients that have a BCDVA of 20/25 or worse in either eye

Ages Eligible for Study

21 Years to 38 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Daniel Terveen,

Study Record Dates

2023-12-01